Global Blood Therapeutics, Inc. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Indenture Agreements (2 contracts)
- Investor Rights Agreements (2)
- Loan Agreements (1)
- Stock Agreements (3)
- Term Sheets (1)
- Underwriting Agreements (6)
- First Supplemental Indenture, dated as of October 5, 2022, between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on October 5, 2022)
- Indenture, dated as of December 17, 2021, between Global Blood Therapeutics, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on December 17, 2021)
- Amended and Restated 2015 Employee Stock Purchase Plan (Filed With SEC on May 6, 2020)
- Loan Agreement by and among the Registrant, BioPharma Credit PLC, and Biopharma Credit Investments V (Master) LP, dated December 17, 2019 (Filed With SEC on February 26, 2020)
- Underwriting Agreement dated June 26, 2019 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 28, 2019)
- Underwriting Agreement dated December 7, 2018 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters (Filed With SEC on December 12, 2018)
- Underwriting Agreement dated March 8, 2018 by and between Global Blood Therapeutics, Inc. and Wells Fargo Securities, LLC, as representative of the several underwriters (Filed With SEC on March 12, 2018)
- Underwriting Agreement dated December 15, 2017 by and between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters (Filed With SEC on December 19, 2017)
- 5,102,041 Shares GLOBAL BLOOD THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 22, 2017)
- Pricing Term Sheet [None.] (Filed With SEC on June 20, 2016)
- GLOBAL BLOOD THERAPEUTICS, INC. FIRST AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on March 29, 2016)
- GLOBAL BLOOD THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 31, 2015)
- [] Shares Global Blood Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT [], 2015 (Filed With SEC on July 31, 2015)
- GLOBAL BLOOD THERAPEUTICS, INC. 2012 STOCK OPTION AND GRANT PLAN (Filed With SEC on July 8, 2015)
- GLOBAL BLOOD THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 8, 2015)
